Tag Archives: Patients

Vireo Health of New York

Vireo Launches New York City & Long Island’s First-Ever Medical Marijuana Home Delivery Program

Vireo Launches New York City & Long Island’s First-Ever Medical Marijuana Home Delivery Program

NEW YORK, April 21, 2017 /Weed Wire/ — Today, Vireo Health of New York (“Vireo”), one of only five companies licensed by New York State to cultivate, manufacture and dispense medical marijuana, will launch New York City and Long Island’s first-ever medical marijuana home delivery program.

Department of Health Selects Vendor for Medical Marijuana ‘Seed-to-Sale’ Tracking System

HARRISBURG, Penn., April 20, 2017 /Weed Wire/ – Today, Secretary of Health Karen Murphy announced that the Department of Health has selected MJ Freeway to implement the seed-to-sale electronic tracking system for Pennsylvania’s Medical Marijuana Program.

Mountain State Medicine: West Virginia Governor Legalizes Medical Cannabis

Mountain State Medicine: West Virginia Governor Legalizes Medical Cannabis

On April 19, 2017, West Virginia Gov. Jim Justice signed Senate Bill 386, also known as the West Virginia Medical Cannabis Act, legalizing medical cannabis as a treatment option for patients suffering from one of several qualifying conditions.

University of Utah Hospital Denied Teen Transplant Due to Marijuana Use

University of Utah Hospital Denied Teen Transplant Due to Marijuana Use

A teenager in Utah was denied a life-saving organ transplant by the University of Utah Hospital after it was discovered that the teen had traces of THC in his blood stream.

New York Reminds Insurers to Cover Visits Resulting in MMJ Certification

New York Reminds Insurers to Cover Visits Resulting in MMJ Certification

On April 12, 2017, the NYSDFS announced that it has reminded state-authorized health insurers that they must provide coverage for office visits that fall under the insured’s policy of covered services, including those resulting in patients receiving medical marijuana certifications.

DFS

DFS Reminds Health Insurers of Their Obligation to Cover Office Visits That Also Include Medical Marijuana Certification Among Other Healthcare Services

ALBANY, N.Y., April 12, 2017 /Weed Wire/ — Department of Financial Services is reminding all insurers authorized to write insurance in New York State that they must provide coverage for office visits for covered services, including those that may result in a medical marijuana certification, as long as the visit was not solely for the purpose of the certification.

Massachusetts Banked $7.2M in Medical Marijuana Revenue in 2016

Massachusetts Banked $7.2M in Medical Marijuana Revenue in 2016

According to the Medical Marijuana Trust Fund Annual Report, issued by the Massachusetts Department of Public Health for fiscal year 2016, the state collected approximately $7.2 million in revenue from its medical marijuana program.

Drug Policy Alliance deportation

Decision Pending on Adding Opioid Use Disorder for Medical Marijuana in New Mexico

SANTA FE, N.M., April 7, 2017 /Weed Wire/ — On Friday, April 7, New Mexico could become the first state in the nation to specifically list opioid use disorder as medical condition that qualifies for access to the state medical marijuana program.

Illinois Medical Cannabis Sales Surge by Nearly $2 Million in March

Illinois Medical Cannabis Sales Surge by Nearly $2 Million in March

On April 5, 2017, the Illinois Medical Cannabis Pilot Program announced that it brought in approximately $6.3 million in retail medical marijuana sales for the month of March, a nearly $2 million surge from the $4.9 million in sales for the month of February.

Canopy Growth to launch online marijuana store in April

Canopy Growth to Launch Online Marijuana Store in April

Online sales could be one way recreational marijuana is sold after legalization. Canopy Growth, the parent company of Tweed, Bedrocan, and Mettrum, is preparing to launch a website that will sell marijuana from all three producers in one place.

NYSDOH Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana

New York State Department of Health Announces Latest Enhancements to Improve Patient Access to Medical Marijuana Program

ALBANY, N.Y., March 16, 2017 /Weed Wire/ — The New York State Department of Health today announced several enhancements to the state’s Medical Marijuana Program that will improve patient access. These measures include authorizing physician assistants to certify patients and adding chronic pain as a qualifying condition.

Massachusetts Legislature Considers Workplace Protections for MMJ Patients

Massachusetts Legislature Considers Workplace Protections for MMJ Patients

Should businesses be able to fire workers for using medical marijuana, even if it’s legal under state law? That’s a question that the Massachusetts Legislature is currently considering as it debates a pair of bills that would extend legal protections to medical marijuana patients in the workplace.

World of Cannabis - Medical Marijuana State Initiatives

World of Cannabis: Medical Marijuana State Initiatives

Watch the World of Cannabis in Las Vegas tackle the details of medical marijuana state initiatives. Matthew Abel, attorney and director of Michigan NORML, covers recent medical marijuana developments in Michigan. Ari Gerstin, an attorney in Miami, and Michael C. Minardi, Senior Partner at Minardi Law, provide an update on medical marijuana in Florida.

wellness-connection-of-maine-web-logo

Wellness Connection of Maine Now Offers Debit Payment Option

PORTLAND, Maine, March 16, 2017 /Weed Wire/ — Wellness Connection of Maine (WCM), the state’s largest medical cannabis operator, now offers members the ability to pay for cannabis without using cash. A new mobile app, CanPay, is the first of its kind technology for the cannabis industry.

Medical Marijuana Inc.

Study Results: Medical Marijuana, Inc. Subsidiary HempMeds Mexico Announces Release of Study Using Its Real Scientific Hemp Oil-X to Treat Epileptic Children

SAN DIEGO, Calif., March 14, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico is holding a press conference in Mexico City, Mexico, today to reveal the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy.

Zynerba

Zynerba Pharmaceuticals Announces Completion of Enrollment for ZYN002 in Two Phase 2 Clinical Trials for Epilepsy and Osteoarthritis

DEVON, Penn., March 13, 2017 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that it has completed enrollment in the Phase 2 STAR 1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial evaluating ZYN002 cannabidiol (CBD) gel in adult epilepsy patients with refractory focal seizures.

Medical Marijuana Inc.

Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum

NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.

Drug Policy Alliance deportation

Bipartisan Vote Carries Medical Marijuana Research Bill to Passage in New Mexico State House

Saturday afternoon, the New Mexico State House voted (41-26) to pass House Bill 155, co-sponsored by Rep. D. Armstrong (D-Albuquerque) and Rep. McCamley (D-Las Cruces) to establish a fund in the state treasury for research related to the production, uses, effects, and efficacy of medical marijuana.

Illinois_Department_of_Health

Illinois Department of Public Health Provides Medical Marijuana Program Update

SPRINGFIELD, Ill., March 2, 2017 /Weed Wire/ — The Illinois Department of Public Health (IDPH) has approved applications for approximately 16,990 qualifying patients (including 139 persons under 18 years of age), since it began accepting applications for the Medical Cannabis Registry Program on September 2, 2014.

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.

Science and Medicine of Cannabis: What Role Will FDA Play in Medical Cannabis?

Science and Medicine of Cannabis: What Role Will FDA Play in MMJ?

Stephen Goldner, Senior Forensic Toxicologist at Quantum 9, learned early on how to work with the FDA, having developed the FDA-approved liquid dose form of methadone with his mentor John Broich. Hear Goldner discuss what role the FDA would likely play in life after medical cannabis legalization.

Conn DCP

Consumer Protection Commissioner Proposed New Medical Marijuana Conditions

HARTFORD, Conn., Feb. 23, 2017 /Weed Wire/ — Today, Commissioner Jonathan A. Harris informed the Board of Physicians of his decision regarding which conditions DCP will seek to add to the list of debilitating conditions through the regulation making process.

NJ Patients beg treat pain with MMJ

NJ Patients Beg: Treat Pain With Medical Marijuana Instead of Opioids

As Gov. Chris Christie travels the state on an aggressive campaign to end an epidemic of heroin and prescription drug overdoses, more than two dozen New Jersey citizens came to the capital city Wednesday to offer him a new strategy.


Page 1 of 912345...Last »
Top